Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

Ruxolitinib helped a patient with alopecia areata regrow hair.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Upadacitinib may effectively treat alopecia areata without side effects.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Tapering and stopping tofacitinib may be possible for young alopecia areata patients.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Activating PKM2 and Wnt/β-catenin signaling speeds up wound healing.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.